Skip to main content
# Title Department Research Year
351 CK2 Inhibition, Lipophilicity and Anticancer Activity of New N1 Versus N2-Substituted Tetrabromobenzotriazole Regioisomers Department of Pharmaceutical Organic Chemistry 2020
352 Nanomedicine Fight against Antibacterial Resistance: An Overview of the Recent Pharmaceutical Innovations Department of Pharmaceutics 2020
353 Pencil Graphite Electrode Decorated with Xylenol Orange Flakes for Studying Possible Pharmacokinetic Interaction Between Vardenafil and Daclatasvir Department of Pharmaceutical Analytical Chemistry 2020
354 Optimization of A Sensitive and Robust Strategy for MEKC Analysis of Sofosbuvir in Combination with its Co-Formulated Hepatitis C Antiviral Drugs Department of Pharmaceutical Analytical Chemistry 2020
355 Novel Class of Benzimidazole-Thiazole Hybrids: The Privileged Scaffolds of Potent Anti-Inflammatory Activity with Dual Inhibition of Cyclooxygenase and 15-Lipoxygenase Enzymes Department of Pharmaceutical Organic Chemistry 2020
356 Design, Synthesis and Biological Evaluation of Novel 5-((substituted quinolin-3-yl /1-naphthyl) methylene)-3-substituted imidazolidin-2,4-dione as HIV-1 Fusion Inhibitors Department of Pharmaceutical Organic Chemistry 2020
357 Dual-recognition molecularly imprinted aptasensor based on gold nanoparticles decorated carboxylated carbon nanotubes for highly selective and sensitive determination of histamine in different matrices Department of Pharmaceutical Analytical Chemistry 2020
358 Cytotoxic Activity of Abietane-Type Diterpenes Isolated From Taxodium distichum Against Cancer Cells Adapted to Nutrient-Starved Conditions Department of Pharmacognosy 2020
359 Evaluation of autophagy-related genes in Egyptian systemic
lupus erythematosus patients
2020
360 Further Insight Into the Dual COX-2 and 15-LOX Anti-Inflammatory Activity of 1,3,4-Thiadiazole-thiazolidinone Hybrids: The Contribution of the Substituents at 5th Positions is Size Dependent Department of Pharmaceutical Organic Chemistry 2020